These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30552114)

  • 41. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins.
    Cai Y; Baer-Dubowska W; Ashwood-Smith MJ; Ceska O; Tachibana S; DiGiovanni J
    Chem Res Toxicol; 1996 Jun; 9(4):729-36. PubMed ID: 8831817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
    Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P
    J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.
    Gay SC; Roberts AG; Halpert JR
    Future Med Chem; 2010 Sep; 2(9):1451-68. PubMed ID: 21103389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of Species-Selectivity of Human, Mouse and Rat Cytochrome P450 1A and 2B Subfamily Enzymes using Molecular Modeling, Docking and Dynamics Simulations.
    Karthikeyan BS; Suvaithenamudhan S; Akbarsha MA; Parthasarathy S
    Cell Biochem Biophys; 2018 Jun; 76(1-2):91-110. PubMed ID: 28353142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain.
    Morse DC; Stein AP; Thomas PE; Lowndes HE
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):232-9. PubMed ID: 9772218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis.
    Lewis BC; Mackenzie PI; Miners JO
    Arch Biochem Biophys; 2007 Dec; 468(1):58-69. PubMed ID: 17959138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ferrous and ferric state of cytochromes P450 in intact Escherichia coli cells: a possible role of cytochrome P450-flavodoxin interactions.
    Culka M; Milichovsky J; Jerabek P; Stiborova M; Martinek V
    Neuro Endocrinol Lett; 2015; 36 Suppl 1():29-37. PubMed ID: 26757119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An amperometric biosensor based on rat cytochrome p450 1A1 for benzo[a]pyrene determination.
    Wu Y; Liu X; Zhang L; Wang C
    Biosens Bioelectron; 2011 Jan; 26(5):2177-82. PubMed ID: 20947330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytochrome P450 (CYP) mutants and substrate-specificity alterations: segment-directed mutagenesis applied to human CYP1A1.
    Urban P; Jobert AS; Lainé R; Pompon D
    Biochem Soc Trans; 2001 May; 29(Pt 2):128-35. PubMed ID: 11356140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural basis of species differences between human and experimental animal CYP1A1s in metabolism of 3,3',4,4',5-pentachlorobiphenyl.
    Yamazaki K; Suzuki M; Itoh T; Yamamoto K; Kanemitsu M; Matsumura C; Nakano T; Sakaki T; Fukami Y; Imaishi H; Inui H
    J Biochem; 2011 Apr; 149(4):487-94. PubMed ID: 21258071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
    Shiota N; Kodama S; Inui H; Ohkawa H
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway.
    Chiaro CR; Patel RD; Marcus CB; Perdew GH
    Mol Pharmacol; 2007 Nov; 72(5):1369-79. PubMed ID: 17720764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
    Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
    Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytochrome P450 active site plasticity: attenuation of imidazole binding in cytochrome P450(cam) by an L244A mutation.
    Verras A; Alian A; de Montellano PR
    Protein Eng Des Sel; 2006 Nov; 19(11):491-6. PubMed ID: 16943206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes.
    Dhawan A; Parmar D; Dayal M; Seth PK
    Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.
    Stiborová M; Sopko B; Hodek P; Frei E; Schmeiser HH; Hudecek J
    Cancer Lett; 2005 Nov; 229(2):193-204. PubMed ID: 16125300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.
    Lee D; Perez P; Jackson W; Chin T; Galbreath M; Fronczek FR; Isovitsch R; Iimoto DS
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3243-3247. PubMed ID: 27265259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
    Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.